Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCI

Conditions:   Diabetes Mellitus, Type 2;   Coronary Artery Disease Interventions:   Drug: Ticagrelor;   Drug: Clopidogrel Sponsors:   University of Florida;   AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials